SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-18-118655
Filing Date
2018-04-16
Accepted
2018-04-16 16:59:03
Documents
83

Document Format Files

Seq Description Document Type Size
1 S-1 d546542ds1.htm S-1 1778208
2 EX-1.1 d546542dex11.htm EX-1.1 144915
3 EX-5.1 d546542dex51.htm EX-5.1 8395
4 EX-23.1 d546542dex231.htm EX-23.1 1364
11 GRAPHIC g546542g01w25.jpg GRAPHIC 50084
12 GRAPHIC g546542g0416080837376.jpg GRAPHIC 1649
13 GRAPHIC g546542g06a41.jpg GRAPHIC 36494
14 GRAPHIC g546542g22d56.jpg GRAPHIC 25864
15 GRAPHIC g546542g24u77.jpg GRAPHIC 69805
16 GRAPHIC g546542g36v72.jpg GRAPHIC 85162
17 GRAPHIC g546542g40k79.jpg GRAPHIC 58162
18 GRAPHIC g546542g67i47.jpg GRAPHIC 75528
19 GRAPHIC g546542g73l75.jpg GRAPHIC 56813
20 GRAPHIC g546542g87j45.jpg GRAPHIC 146661
21 GRAPHIC g546542g92d12.jpg GRAPHIC 41335
22 GRAPHIC g546542g92h88.jpg GRAPHIC 29211
23 GRAPHIC g546542g96h93.jpg GRAPHIC 127605
24 GRAPHIC g546542ph1.jpg GRAPHIC 9834
  Complete submission text file 0001193125-18-118655.txt   8293062

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT apls-20171231.xml EX-101.INS 1590758
6 XBRL TAXONOMY EXTENSION SCHEMA apls-20171231.xsd EX-101.SCH 58027
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20171231_cal.xml EX-101.CAL 34146
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20171231_def.xml EX-101.DEF 186369
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20171231_lab.xml EX-101.LAB 427744
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20171231_pre.xml EX-101.PRE 322240
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-224303 | Film No.: 18757154
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences